[go: up one dir, main page]

PL2089030T3 - Środek do zapobiegania lub leczenia uzależnienia od alkoholu lub uzależnienia od narkotyków - Google Patents

Środek do zapobiegania lub leczenia uzależnienia od alkoholu lub uzależnienia od narkotyków

Info

Publication number
PL2089030T3
PL2089030T3 PL07830236T PL07830236T PL2089030T3 PL 2089030 T3 PL2089030 T3 PL 2089030T3 PL 07830236 T PL07830236 T PL 07830236T PL 07830236 T PL07830236 T PL 07830236T PL 2089030 T3 PL2089030 T3 PL 2089030T3
Authority
PL
Poland
Prior art keywords
dependence
prophylaxis
agent
treatment
alcohol
Prior art date
Application number
PL07830236T
Other languages
English (en)
Inventor
Koji Teshima
Roberto Ciccocioppo
Maurizio Massi
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of PL2089030T3 publication Critical patent/PL2089030T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL07830236T 2006-10-16 2007-10-16 Środek do zapobiegania lub leczenia uzależnienia od alkoholu lub uzależnienia od narkotyków PL2089030T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06122336 2006-10-16
EP07830236A EP2089030B1 (en) 2006-10-16 2007-10-16 Agent for prophylaxis or treatment of alcohol dependence or drug dependence
PCT/JP2007/070502 WO2008050698A2 (en) 2006-10-16 2007-10-16 Agent for prophylaxis or treatment of alcohol dependence or drug dependence

Publications (1)

Publication Number Publication Date
PL2089030T3 true PL2089030T3 (pl) 2012-02-29

Family

ID=37806857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07830236T PL2089030T3 (pl) 2006-10-16 2007-10-16 Środek do zapobiegania lub leczenia uzależnienia od alkoholu lub uzależnienia od narkotyków

Country Status (16)

Country Link
US (1) US8207201B2 (pl)
EP (1) EP2089030B1 (pl)
JP (1) JP5089687B2 (pl)
KR (1) KR101187509B1 (pl)
CN (1) CN101600433B (pl)
AT (1) ATE524180T1 (pl)
AU (1) AU2007310209B2 (pl)
BR (1) BRPI0717161A2 (pl)
CA (1) CA2666630C (pl)
DK (1) DK2089030T3 (pl)
ES (1) ES2370276T3 (pl)
MX (1) MX2009004012A (pl)
PL (1) PL2089030T3 (pl)
PT (1) PT2089030E (pl)
RU (1) RU2419433C2 (pl)
WO (1) WO2008050698A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201016675A (en) * 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
TWI582096B (zh) * 2011-12-06 2017-05-11 美國禮來大藥廠 用於酒精依賴及濫用處理之４',５'－二氫螺［哌啶－４,７'－噻吩并[２，３－c]哌喃］化合物
CN117642389A (zh) * 2021-07-14 2024-03-01 宜昌人福药业有限责任公司 一种哌啶衍生物及其药物组合物、制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1049689E (pt) * 1998-01-19 2002-09-30 Pfizer Compostos de 4-(2-ceto-1-benzimidazolinil)piperidina como agonistas do receptor orl1
DK1491212T3 (da) * 2002-03-29 2012-10-29 Mitsubishi Tanabe Pharma Corp Middel til behandling af søvnforstyrrelser
TW200519101A (en) * 2003-09-25 2005-06-16 Solvay Pharm Bv Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
WO2006025267A1 (ja) * 2004-08-31 2006-03-09 Mitsubishi Pharma Corporation Per2タンパク質レベルの低下を作用機序とする睡眠障害治療薬
TW201016675A (en) * 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof

Also Published As

Publication number Publication date
RU2009118439A (ru) 2010-11-27
JP2010505746A (ja) 2010-02-25
EP2089030A2 (en) 2009-08-19
MX2009004012A (es) 2009-04-27
JP5089687B2 (ja) 2012-12-05
AU2007310209A1 (en) 2008-05-02
ES2370276T3 (es) 2011-12-14
RU2419433C2 (ru) 2011-05-27
EP2089030B1 (en) 2011-09-14
CN101600433B (zh) 2012-09-26
AU2007310209B2 (en) 2011-11-17
US20100069382A1 (en) 2010-03-18
PT2089030E (pt) 2011-09-27
WO2008050698A2 (en) 2008-05-02
US8207201B2 (en) 2012-06-26
ATE524180T1 (de) 2011-09-15
KR101187509B1 (ko) 2012-10-02
CA2666630A1 (en) 2008-05-02
BRPI0717161A2 (pt) 2013-10-15
CN101600433A (zh) 2009-12-09
CA2666630C (en) 2012-01-24
WO2008050698A3 (en) 2008-10-02
DK2089030T3 (da) 2011-12-05
KR20090069336A (ko) 2009-06-30

Similar Documents

Publication Publication Date Title
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
MX2009008541A (es) Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c.
GEP20104906B (en) Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
JO2962B1 (en) Aminopronic derivatives substituted as niprilicin inhibitors
WO2009144555A8 (en) Pyrazolospiroketone acetyl-coa carboxylase inhibitors
MX2009000482A (es) Compuestos terapeuticos.
WO2007087548A3 (en) Chemical compounds
MX2009005604A (es) Inhibidores espiro cetona de acetil-coa carboxilasa.
AU2012243329A8 (en) 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
MX2009002010A (es) Derivados de heteroarilo como inhibidores de la proteina cinasa.
HK1203497A1 (en) Non-systemic tgr5 agonists
TW200517106A (en) Sustained release pharmaceutical compositions
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
SG171635A1 (en) Therapeutic piperazines as pde4 inhibitors
DK2054418T3 (da) Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer
TNSN08529A1 (en) Inhibitors of akt (protein kinase b)
TW200806291A (en) Pharmaceutical formulations
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
GEP20115230B (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4
WO2007002313A3 (en) Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
EA201071395A1 (ru) Ингибитор толерантности к анальгетику
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
GEP20125389B (en) Substituted pyrazole and triazole compounds as ksp inhibitors
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.